Login / Signup

Another case of generalized bullous fixed drug eruption following an adenoviral vector-based COVID-19 vaccine (ChAdOx1 nCov-19).

Chaker Ben SalemA KhelifD SahnounN GharianiB SrihaM Denguezli
Published in: Journal of the European Academy of Dermatology and Venereology : JEADV (2022)
Keyphrases
  • coronavirus disease
  • sars cov
  • adverse drug
  • respiratory syndrome coronavirus
  • electronic health record